Imperial News

Scientists identify specific enzymes that make meningitis hard to fight

Molecular bioscientists and doctors work together to understand the virulence of infection - <em>News Release</em>

See also...

Division of Molecular Biosciences

Division of Investigative Science


External sites:

The Meningitis Research Foundation

The Meningitis Trust

(Imperial College is not responsible for the content of these external internet sites)

Imperial College London News Release

Under strict embargo for
17.00 hours GMT
Thursday 22 February 2007

Two enzymes in meningitis bacteria which prevent the body from successfully fighting off the disease, and make the infection extremely virulent, have been identified in new research published today.

The study found that the two enzymes - which have distinct functions - work together to hamper the body's efforts to fight off the disease. Together they repair damage done to the meningitis bacteria's DNA by the body's white blood cells, which are sent to fight the infection.

Understanding the part these enzymes play in the process that enables the bacteria to elude the body's natural defences could eventually help scientists develop novel new treatments for meningitis and the septicaemia it can cause. Both are extremely serious conditions with a high mortality rate, which take hold quickly and are difficult to treat - sometimes resulting in extreme measures such as limb amputation.

When the meningitis bacteria enter the bloodstream, the body's natural defences send white blood cells to fight the infection. They ingest the bacteria and subject them to oxidative stress. Oxidative stress damages the base chemical compounds of the bacteria's DNA. This should lead to cell death and the defeat of the bacteria. However, the virulent meningitis bacteria are able to repair this harmful damage and are therefore unaffected by the body's defences.

The research team found that the two enzymes essential to the bacteria's repair mechanism are AP endonuclease and 3'-phosphodiesterase. Contrary to the scientists' expectations, these two enzymes carry out separate functions in the DNA repair process.

Professor Paul Freemont   from Imperial's Division of Molecular Biosciences explains: "Scientists have long understood that the secret of meningitis' virulence lies in its ability to rearrange its DNA and thus change its external appearance to the body's immune system. Significantly our research has now demonstrated that the ability of meningitis to repair its DNA is important for its ability to survive attack from the body's immune system. This work provides an insight into the precise roles of two enzymes in mending DNA and gives us a greater understanding than ever before into why these infections are so hard for the body to fight.

"We have also discovered that this novel combination of enzymes is present in a wide variety of bacteria and that it has a direct impact on the infectivity of human pathogens."

Dr Geoff Baldwin  from Imperial's Division of Molecular Biosciences added: "The wide importance of DNA repair to the viability of all organisms is well established. However, for the first time this research shows an important role for DNA repair in meningitides fighting off the attack of the body's immune system.

"We have examined two enzymes from a family that are known to cut the DNA during its repair. To our surprise we discovered that in the meningitis bacteria, one of the enzymes does not cut the DNA. Instead, it removes damaged DNA ends that prevent the DNA from being remade during the repair process. This has an important impact for our understanding of the precise pathways of DNA repair and the significance of the two separate functionalities that act in different DNA repair pathways within the pathogen."

Professor Christoph Tang   from Imperial's Division of Investigative Science added: "After realising that the two enzymes had distinct roles repairing different types of DNA damage, we were able show the pathogen can 'fend off' different types of DNA damage while in the bloodstream. In theory, finding some way of disabling these enzymes would render the bacteria unable to repair itself, and therefore vulnerable to attack and defeat by the body's immune system."

-Ends-

For more information please contact:
Danielle Reeves, Imperial College London press office
Tel: +44 (0)20 7594 2198
Mob: +44 (0)7803 886248
Email: Danielle.reeves@imperial.ac.uk

Notes to editors:

1. 'AP endonuclease paralogues with distinct activities in DNA repair and bacterial pathogenesis', The EMBO Journal, Advanced Online Publication - 22 February 2007.

Elisabth P. Carpenter (1), Anne Corbett (2), Hellen Thomson (1), Jolanta Adacha (1), Kirsten Jensen (1), Julien Bergeron (1), Ioannis Kasampalidis (1), Rachel Exley (2), Megan Winterbotham (2), Christoph Tang (2), Geoff S. Baldwin (1), Paul Freemont (1).

(1) Centre for Structural Biology, Division of Molecular Biosciences, Faculty of Natural Sciences and
(2) Centre for Molecular Microbiology and Infection, Department of infectious Diseases, Faculty of Medicine, Imperial College London, SW7 2AZ

2. About Imperial College London

Rated as the world's ninth best university in the 2006 Times Higher Education Supplement University Rankings, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 11,500 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture. With 62 Fellows of the Royal Society among our current academic staff and distinguished past members of the College including 14 Nobel Laureates and two Fields Medallists, Imperial's contribution to society has been immense. Inventions and innovations include the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of our research for the benefit of all continues today with current focuses including interdisciplinary collaborations to tackle climate change and mathematical modelling to predict and control the spread of infectious diseases. The College's 100 years of living science will be celebrated throughout 2007 with a range of events to mark the Centenary of the signing of Imperial's founding charter on 8 July 1907. Website: www.imperial.ac.uk